Trademark Overview
On Tuesday, November 26, 2024, a trademark application was filed for MIMIX with the United States Patent and Trademark Office. The USPTO has given the MIMIX trademark a serial number of 98873501. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, November 26, 2024. This trademark is owned by Revvity Health Sciences, Inc.. The MIMIX trademark is filed in the Chemical Products, Pharmaceutical Products, and Treatment & Processing of Materials Services categories with the following description:
Custom manufacture of cell line-delivered products for medical and commercial applications; Custom manufacture of reference standards
cell line-derived reference standards used in clinical samples; Reference standard substances used for clinical tests for medical purposes; Reference standards used for next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing; Reference standards used for detecting chromosomal abnormalities; Reference standards used for analysing biological samples
Biological preparations for laboratory, biopharmaceutical processing, and research purposes, namely, reference standards; Biological preparations for cancer research; Biological preparations for quality control; Cell line-derived reference standards for research purpose; Samples for use in biochemical or biological laboratory analysis for research purposes; Cell line-derived products for scientific and research purposes, including for clinical investigations and for use in product testing; Reference standards used for research purposes, namely, next generation sequencing, droplet-digital, Real-Time PCR or Sanger sequencing